Posted by The 20th IDDST (Europe) will be held during June 17-19, 2024 at Budapest, Hungary.
200+ participants from 35 countries will gather in beautiful Budapest for the event. It will provide a unique and ideal opportunity focusing on drug discovery, advanced pharmaceutical sciences, new technologies, drug delivery systems, clinical application, next generation biotherapy, industrial R & D and pipeline new drugs, translational medicine, Bioprocessing & Manufacturing and Integrative Services.
There are some confirmed speakers now:
- Dr. Laszlo Takacs, Professor, University of Debrecen; CEO/CSO Biosystems Immunolab Zrt, Hungary; Foreign Member of the Hungarian Academy of Sciences
- Dr. Alexey Rak, Head of Bio Structure and Biophysics, Sanofi R & D, France
- Dr. Stefan Platz, SVP & Global Head Clinical Pharmacology & Safety Sciences, AstraZeneca, USA
- Dr. Aram Oganesian, Vice President, Clinical Pharmacology & NonClinical Development, Astex Pharmaceuticals, USA
- Dr. Gabriel P. Haas, Senior Medical Director, Global Medical Affairs, Astellas Pharma, USA
- Dr. Pál Perjési, Professor, Institute of Pharmaceutical Chemistry, University of Pecs, Hungary
- Dr. Virginia Savova, Senior Director, Global Head of Single-cell Biology, Sanofi, USA
- Dr. Mark S McAlister, Director of Biophysics, AstraZeneca, UK
- Dr. Adel K El-Naggar, Professor, The University of Texas, MD Anderson Cancer Center, USA
- Dr. Irena Kostova, Professor, Faculty of Pharmacy, Medical University-Sofia, Bulgaria
- Dr. Robert F. Halliwell, Professor, School of Pharmacy, University of the Pacific, USA
- Dr. Grace-Hyun J. Kim, Professor, University of California, Los Angeles, USA
- Dr. Philippe Lechat, Pharmacology Emeritus Professor, Paris city University, France
- Dr. Leandro Castellano, Head of Department of Biochemistry and Biomedicine, University of Sussex, UK
- Dr. Chunyu Wang, Professor, Rensselaer Polytechnic Institute, USA
- Dr. Rebeca Ruiz, Principal Scientist, Pion Inc., UK
- Dr. Dawei Li, Professor, School of Pharmacy, Shanghai Jiao Tong University Shanghai, China
- Dr. Yuxun Wang, CEO, Applied Pharmaceutical Science, Inc., China
- Dr. Salvatore Guccione, Professor, Central Drug Research Institute, Italy
- Dr. Andrzej Pilc, Professor, Institute of Pharmacology, Polish Academy of Sciences, Poland
- Dr. Hubert Pellikaan, Owner, Nextstep Pharma BV; Co-Founder, DriPel BV, the Netherlands
- Dr. Mahmood Moshiri, President and CEO, Next Pharma Inc., Canada
- Dr. James A Stones, Patent Attorney, Beck Greener LLP, UK
- Dr. Catherine Jewell, Patent and Trade Mark Attorney, Beck Greener LLP, UK
- Dr. Sergey Suchkov, Professor in Immunology & Medicine, MGUPP, Russia
- Mr. Thomas Ko, CTO, BioLingus GmbH, Switzerland
- Dr. Robert T Chatterton, Professor Emeritus of Obstetrics and Gynecology, Northwestern University, USA
- Dr. Tomas Komprda, Professor, Mendel University in Brno, Czech Republic
- Dr. Petr Maly, Head of Laboratory of Ligand Engineering, Institute of Biotechnology of Czech Academy of Sciences, Czech Republic
- Dr. Peter A. Bretscher, Professor, Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Canada
- Dr. Mohamed Al-Ibrahim, Senior Physician Investigator, Pharmaron CPC; Adjunct Professor of Medicine, University of Maryland, School of Medicine, USA
- Dr. Gitanjali Srivastava, Associate Professor, Vanderbilt University School of Medicine, USA
- Dr. Pedro J. Caraballo, Associate Professor, Mayo Clinic College of Medicine and Science, USA
- Dr. Ya Ha, Associate Professor of Pharmacology, Yale School of Medicine, USA
- Dr. Wilfried Schupp, Senior Lecturer, Friedrich Alexander University, Germany
- Dr. Sonia Laneri, Associate Professor, Department of Pharmacy, University of Naples Federico II, Italy
- Dr. Hanzhou Feng, Senior Scientist, Data Rich Measurements, Merck & Co., Inc., USA